RLFTF   $8.6  7.50% Market Closed

Relief Therapeutics Holding AG
Total Cash
totalCashPerShare
EBITDA
Total Debt
quickRatio
currentRatio
Total Revenue
debtToEquity
Revenue/Share 0.513
ROA
ROE
grossProfits
freeCashflow
operatingCashflow
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue
forwardPE
floatShares
sharesOutstanding 12.54M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.0
heldPercentInstitutions 0.27%
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue 4.165
Price To Book help_outline 1.49
earningsQuarterlyGrowth
netIncomeToCommon
trailingEps -4.22%
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 12
lastUpdated Oct. 16, 2024, 9:45 p.m.